Disease | Target Count | P-value |
---|---|---|
non-small cell lung cancer | 2890 | 2.1e-19 |
tuberculosis | 2010 | 2.1e-06 |
malignant mesothelioma | 3232 | 3.9e-06 |
ovarian cancer | 8520 | 6.5e-06 |
ependymoma | 4679 | 2.6e-05 |
osteosarcoma | 7950 | 6.3e-05 |
atypical teratoid / rhabdoid tumor | 5112 | 9.3e-05 |
Down syndrome | 499 | 2.7e-04 |
lung adenocarcinoma | 2716 | 2.8e-04 |
medulloblastoma, large-cell | 6241 | 1.3e-03 |
subependymal giant cell astrocytoma | 2287 | 2.5e-03 |
group 4 medulloblastoma | 1855 | 6.0e-03 |
primary Sjogren syndrome | 735 | 7.7e-03 |
spina bifida | 1074 | 4.7e-02 |
Disease | log2 FC | p |
---|---|---|
atypical teratoid / rhabdoid tumor | -1.300 | 9.3e-05 |
Down syndrome | 1.800 | 2.7e-04 |
ependymoma | -1.100 | 2.6e-05 |
group 4 medulloblastoma | -1.300 | 6.0e-03 |
lung adenocarcinoma | 1.222 | 2.8e-04 |
malignant mesothelioma | 1.400 | 3.9e-06 |
medulloblastoma, large-cell | -1.600 | 1.3e-03 |
non-small cell lung cancer | -1.038 | 2.1e-19 |
osteosarcoma | -1.274 | 6.3e-05 |
ovarian cancer | -1.900 | 6.5e-06 |
primary Sjogren syndrome | 1.100 | 7.7e-03 |
spina bifida | -1.083 | 4.7e-02 |
subependymal giant cell astrocytoma | -2.566 | 2.5e-03 |
tuberculosis | -1.100 | 2.1e-06 |
Species | Source | Disease |
---|---|---|
Inparanoid OMA | ||
Inparanoid OMA | ||
Inparanoid OMA | ||
Inparanoid OMA | ||
Inparanoid OMA | ||
Inparanoid OMA | ||
Inparanoid OMA | ||
Inparanoid OMA | ||
Inparanoid OMA | ||
Inparanoid OMA | ||
Inparanoid OMA |